ABSTRACT
Background Early recognition of left atrial (LA) and left ventricular (LV) remodelling may improve prognosis of patients with hypertension.
Methods Left heart coupling indices were studied to investigate the adaptive effect of hypertension on cardiac remodelling. The ratio of LV to LA volumes was measured at selected phases of a cardiac cycle using computed tomography (CT) coronary angiography and transthoracic echocardiogram (TTE). A group of 180 patients was divided into Group 1 (no hypertension) and Group 2 (hypertension). Volume ratios were measured in diastasis by both CT and TTE: LVdias and LAdias. Using TTE, volumes were measured at end-diastole (LVED and LAmin)), and end-systole (LVES and LAmax). LA function and LV/LA ratios were analysed at: LVED/LAmax, LVdias/LAdias, LVED/LAmin, LVES/LAmin.
Results There were no differences between the age groups, LVED, and LV mass index. Compared to Group 1, Group 2 had bigger mean LV wall thickness (0.90±0.16 cm vs 0.83±0.14 cm; p=0.006), increased relative wall thickness ratio (0.39±0.09 vs 0.35±0.008, p=0.004), and more frequent concentric LV remodelling (31 vs 12, p=0.020). LA volumes were bigger in Group 2 for LAmax, LAdias, and LAmin. All LV/LA volume ratios were lower in Group 2 compared to Group 1 (LVED/LAmax 1.55±0.56 vs 1.79±0.69, p=0.010; LVED/LAmin 3.56±2.00 vs 4.59±2.56, p=0.003; LVES/LAmin 1.36±0.77, p=0.005, LVdias/LAdias (TTE) 1.75±0.61 vs 2.24±1.24, p<0.001, LVdias/LAdias (CT) 1.49±0.23 vs 1.69±0.41, p<0.001). LA reservoir function and conduit function indexed by E/e’ ratio was lower in Group 2. Combined TTE parameters of relative wall thickness >40, LVdias/LAdias≤1.81, and indexed by E/e’ LA reservoir function ≤0.068 had the highest discriminate power to differential patients from Group 1 and Group 2 (area under the curve 0.737).
Conclusions In hypertension, prior to the development of LV hypertrophy, adaptive remodelling is based on reduced LV/LA volume ratio, reduced indexed reservoir LA function, and increased relative LV wall thickness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was supported by Wesley Medical Research Clinical Research Grant #2020-23.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by UnitingCare Health Human Research Ethics Committee (number 2019.29.307), Brisbane, Australia.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
on request
Abbreviations and non-standard acronyms
- CT
- Computed Tomography
- HF
- Heart Failure
- LA
- Left Atrial/Atrium
- LAdias
- Left Atrial diastasis volume
- LAmax
- Left atrial maximum volume
- LAmin
- Left atrial minimal volume
- LV
- Left Ventricle/Ventricular
- LVdias
- Left Ventricular diastasis volume
- LVED
- Left Ventricular end-diastolic volume
- LVES
- Left Ventricular end-systolic volume
- TTE
- Transthoracic Echocardiogram
